ScholarIQanswers from OpenAlex & ORCID
Bart Neyns
ResearcherPublications, citations & collaboration network
Bart Neyns is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Bart Neyns have?
ScholarIQindexed works
Bart Neyns has 520 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Bart Neyns have?
ScholarIQcitation count
Bart Neyns has 31,850 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Bart Neyns?
ScholarIQh-index
Bart Neyns has an h-index of 68 in OpenAlex.
What is the i10-index of Bart Neyns?
ScholarIQi10-index
Bart Neyns has an i10-index of 219 in OpenAlex.
What is the ORCID of Bart Neyns?
ScholarIQorcid
The ORCID for Bart Neyns is on the source record.
What is the OpenAlex record for Bart Neyns?
ScholarIQopenalex
The OpenAlex for Bart Neyns is on the source record.
What are the most-cited papers on Bart Neyns?
ScholarIQmost cited works
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S. Weber, Sandra P. D’Angelo, David R. Minor, F. Stephen Hodi, Ralf Gutzmer, Bart Neyns, Christoph Höeller, Nikhil I. Khushalani, Wilson H. Miller, Christopher D. Lao, Gerald P. Linette, L. Thomas, Paul Lorigan, Kenneth F. Grossmann, Jessica C. Hassel, Michele Maio, Mario Sznol, Paolo A. Ascierto, Peter Mohr, Bartosz Chmielowski, Alan H. Bryce, Inge Marie Svane, Jean‐Jacques Grob, Angela M. Krackhardt, Christine E. Horak, Alexandre Lambert, Arvin Yang, James Larkin
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
Michael J. Overman, Sara Lonardi, Ka Yeung Mark Wong, Heinz‐Josef Lenz, Fabio Gelsomino, Massimo Aglietta, Michael A. Morse, Eric Van Cutsem, Ray McDermott, Andrew Hill, Michael B. Sawyer, Alain Hendlisz, Bart Neyns, Magali Svrcek, Rebecca A. Moss, Jean-Marie Ledeine, Z. Alexander Cao, Shital Kamble, Scott Kopetz, Thierry André
Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma
Bart Neyns, Jan Sadones, E. Joosens, Frank Bouttens, Luc Verbeke, Jean‐François Baurain, Lionel D’Hondt, Theo Strauven, C. Chaskis, Pieter In 'T Veld, Alex Michotte, Jacques De Grève
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee
Ulrich Keilholz, P.A. Ascierto, Reinhard Dummer, Caroline Robert, Paul Lorigan, Alexander C. J. van Akkooi, Ana Arance, Christian U. Blank, V. Chiarion Sileni, Marco Donia, Mark B. Faries, Caroline Gaudy‐Marqueste, Helen Gogas, Jean‐Jacques Grob, Matthias Gückenberger, John B.A.G. Haanen, Andrew Hayes, Christoph Höeller, Célèste Lebbé, Iwona Ługowska, Mario Mandalà, Iván Márquez‐Rodas, Paul Nathan, Bart Neyns, Roger Olofsson Bagge, Susana Puig, Piotr Rutkowski, Bastian Schilling, Vernon K. Sondak, Hussein A. Tawbi, Alessandro Testori, Olivier Michielin